SMX (Security Matters) Public Limited Company Class A Ordinary Shares (SMX) had the lowest return last year by a small-cap US stock, returning -96.4%.

ASSET	YEAR	% RETURN
SMX (Security Matters) Public Limited Company Class A Ordinary Shares (SMX)	2024	-96.45%
Highest Performances (MAAS)	2024	-94.27%
RAPT Therapeutics (RAPT)	2024	-93.51%
NovaBay Pharmaceuticals (NBY)	2024	-92.21%
mF International Limited Ordinary Shares (MFI)	2024	-91.16%
Roboai (AIIO)	2024	-90.89%
Kyverna Therapeutics, Inc Common Stock (KYTX)	2024	-89.08%
Invivyd (IVVD)	2024	-88.73%
Relmada Therapeutics (RLMD)	2024	-87.74%
Fractyl Health, Inc Common Stock (GUTS)	2024	-86.27%
SolarEdge Technologies (SEDG)	2024	-85.38%
Ginkgo Bioworks (DNA)	2024	-85.21%
Strive Asset Management (ASST)	2024	-84.67%
P3 Health Partners (PIII)	2024	-83.7%
Pacific Biosciences of California (PACB)	2024	-81.11%
Palisade Bio (PALI)	2024	-81.03%
FuelCell Energy (FCEL)	2024	-80.93%
ZKH (ZKH)	2024	-78.33%
Better Home & Finance (BETR)	2024	-77.42%
Meihua International Medical Technologies (MHUA)	2024	-77%
Digital Turbine (APPS)	2024	-74.96%
Sify Technologies (SIFY)	2024	-74.65%
Amylyx Pharmaceuticals (AMLX)	2024	-74.32%
BioAge Labs (BIOA)	2024	-74.27%
Claritev (CTEV)	2024	-73.79%

Small-cap stocks are treated as having a market cap between $300M and $2B.